Latest Chinese Academy of Medical Sciences Stories

BETHESDA, Md., Nov. 1, 2012 /PRNewswire/ -- The National Foundation for Cancer Research (NFCR) and the Chinese Academy of Medical Sciences (CAMS) today announced that they will co-host a high-level symposium in Beijing November 4-6, 2012. The U.S.-China Symposium on State-of-Science Cancer Research and Future Directions for Global Collaboration will bring together leading cancer researchers from the United States and China in an attempt to launch an actionable roadmap for...

TAI'AN, China, Sept. 24 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that on September 11, 2009, the Company entered into a strategic research and development agreement with the Institute of Blood Transfusion (the "IBT") based in Chengdu, Sichuan Province, to strengthen the Company's research...

HUYA to Collaborate on Pre-clinical and Clinical Studies for Chinese Drugs SAN DIEGO, Feb. 18 /PRNewswire/ -- HUYA Bioscience International, the leader in US/China pharmaceutical co-development, today announced a partnership agreement with the Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College (collectively - The Beijing Institute of Materia Medica, BIMM). The agreement grants HUYA the opportunity to collaborate with BIMM on...

IntraOp Medical Corporation (OTCBB: IOPM), a provider of innovative technology solutions for the treatment and eradication of cancer, today announced it has delivered a Mobetron® system to the Cancer Institute & Hospital, Chinese Academy of Medical Sciences (CAMS), Beijing, China. Mobetron is a proprietary, mobile electron-beam instrument designed for Intraoperative Electron Radiation Therapy (IOERT), the direct application of radiation to a tumor while a patient is undergoing...